Recro Pharma is a specialty pharmaceutical company that focuses on developing medical products for hospitals and other acute care settings.
Business Model:
Revenue: $75.4M
Employees: 201-500
Address: 490 Lapp Rd
City: Malvern
State: PA
Zip: 19355
Country: US
Recro Pharma is a specialty pharmaceutical company that focuses on developing medical products for hospitals and other acute care settings.
Contact Phone:
+14843952470
Contact Email:
Listed Exchange:
NASDAQ
IPO Date:
3/6/2014
IPO Valuation:
$56M
Ticker Symbol:
REPH
IPO Price:
$8/share
Amount Raised:
$30M
Opened: -/share
EBITDA | - |
Total Cash | - |
Total Debt | - |
Total Revenue | - |
Total Profit (Gross) | - |
PE Ratio | - |
Announced Date | Company | Transaction | Money Raised |
---|
Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors |
---|---|---|---|---|
6/2015 | Equity | $16M |
Broadfin Capital, LLC |
|
7/2015 | Post-IPO Equity | 1 | $16M |
Broadfin Capital Broadfin Capital Broadfin Capital Broadfin Capital |
4/2015 | Convertible Note | $7.8M | ||
5/2020 | Debt | $2M |
U.S. Small Business Administration. |
|
5/2021 | Post-IPO Equity | $30M | ||
12/2016 | Post-IPO Equity | $40M | ||
3/2019 | Post-IPO Debt | 1 | $40.5M |
Athyrium Capital Management LP Athyrium Capital Management LP Athyrium Capital Management LP Athyrium Capital Management LP |
11/2017 | Post-IPO Debt | 1 | $100M |
Athyrium Capital Management LP Athyrium Capital Management LP Athyrium Capital Management LP Athyrium Capital Management LP |
5/2020 | Debt | $4.4M |
PNC Bank Small Business Administration |
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|